Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Tissue Therapies enters partnerships for wound care product

Dec. 5, 2011

Bristol-Myers Squibb collaborates with Tibotec Pharmaceuticals on phase II HCV trial

Dec. 5, 2011

MacroGenics and Servier enter into license agreement for MGA-271

Dec. 2, 2011

Curis and the Leukemia and Lymphoma Society agree to develop CUDC-907

Dec. 2, 2011

Medunik Canada acquires Canadian rights to two orphan therapies from QOL Medical

Dec. 2, 2011

Dainippon Sumitomo Pharma and Yoshitomiyakuhin to terminate antipsychotic drug copromotion agreement

Dec. 1, 2011

Idera Pharmaceuticals regains global rights to IMO-2055

Dec. 1, 2011

Companies collaborate on spinal muscular atrophy research

Dec. 1, 2011

OncoVista secures CRO for phase Ib study of cordycepin

Nov. 30, 2011

Infinity and Mundipharma extend strategic alliance for PI3K inhibitors

Nov. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...